Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07113236Not ApplicableCompleted

Effectiveness of Interventions for Improving HPV Vaccination Cover

Role: collaborator

NCT05339048Enrolling By Invitation

The Cartagena Cohort Study

Role: lead

NCT02136641Phase 4Completed

Study of Comparison of the Effectiveness of Three Diagrams for Sedation in Spinal Anesthesia

Role: lead

NCT01651988Phase 4Completed

Efficacy of Ketamine-Propofol for Short Surgical Procedures

Role: lead

All 4 trials loaded